EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Selection, Procurement and Distribution
Francisco José Toja Camba, Carmen Lopez Doldan, Laura Casado Vazquez, Aron Misa García, Pilar Rodriguez Rodriguez, Maria Elena Gonzalez Pereira
Hospital Pharmacy must develop new models of pharmaceutical care (PC), improving patients quality of life and enhancing care services. One type of these strategies are non face-to-face PC, such as telepharmacy and home delivery, achieving a new integrated and patient-centered healthcare model.
COVID-19 health crisis and the need to ensure the delivery of medicines to susceptible people and guarantee home isolation, has motivated a paradigm shift in health care.
• Guarantee quality of care in pharmacy consultations (PCC) due to COVID-19 pandemic.
• Implantation of telepharmacy and home delivery of hospital medication.
Three different circuits were designed:
1. Single healthcare act of face-to-face visits in PCC coinciding with other medical appointments. Prior appointment, non-contact consultation agendas and extension of service hours were reinforced.
2. Informed home delivery of hospital medication at home, after prior teleconsultation: pharmacotherapeutic follow-up and request for informed consent. Management and preparation of packages, including motivational messages, to humanize the process. Distribution logistics model based on defined routes and schedules. The confidentiality, security and traceability of the entire process was certified.
3. Open and permanent communication channel between patient and pharmacist that enabled individualized PC.
Patients with mobility problems, home isolation or chronic processes with a higher risk of COVID-19 infection were prioritized.
From March to May 2020, 1,938 pharmacotherapeutic follow-up teleconsultations were carried out (291 patients had been attended in person due to having another medical appointment or due to personal preferences). Medication was home delivered to a total of 1,647 patients. A total of 120 routes were made between the four established routes (average of 15 shipments per working day). Percentage of satisfaction expressed by the patients was 95%.
Main limitations were:
1. Operational challenge: changes in workflows, organization of schedules and work times, increase in telephone lines, route management in a very dispersed geographic area, technology gap (mean age ≥ 60 years) …
2. Human resources.
3. Medication shipping cost.
• Development of new management tools: telepharmacy and home delivery and pharmacotherapeutic follow-up of patients guarantee continuity of non-face-to-face PC.
• We must support initiatives that certify efficient and safe care as well as humanitarian care.
